Page breadcrumb nav

VAERS Report 2156627

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

bnt162b2 has been administered as the third/booster dose and the patient has not previously received the full primary immunization series of bnt162b2 vaccination; bnt162b2 has been administered as the third/booster dose and the patient has not previously received the full primary immunization series of bnt162b2 vaccination; tissue/skin necrosis of two toes, she had a 3rd booster jab with pfizer the toes broke down again within 2 weeks of administration/ necrotic toes nearly healed then broke down again; necrotic toes nearly healed then broke down again; tissue/skin necrosis of two toes, she had a 3rd booster jab with pfizer the toes broke down again within 2 weeks of administration; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority. other case identifier(s): gb-mhra-vac-202202162029458220-ll7la, gb-mhra-adr 26611607. a 70 year-old female patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: covid-19 vaccine astrazeneca (dose 2), administration date: 29may2021, for covid-19 immunisation, reaction(s): "tissue/skin necrosis", "necrotic toes"; covid-19 vaccine (dose 1; manufactuerer unknown), for covid-19 immunisation. the following information was reported: off label use (medically significant), interchange of vaccine products (medically significant), outcome "unknown" and all described as "bnt162b2 has been administered as the third/booster dose and the patient has not previously received the full primary immunization series of bnt162b2 vaccination"; disease recurrence (medically significant), outcome "not recovered", described as "tissue/skin necrosis of two toes, she had a 3rd booster jab with pfizer the toes broke down again within 2 weeks of administration/ necrotic toes nearly healed then broke down again"; skin necrosis (medically significant) with onset 08aug2021, outcome "not recovered", described as "tissue/skin necrosis of two toes, she had a 3rd booster jab with pfizer the toes broke down again within 2 weeks of administration"; extremity necrosis (medically significant), outcome "not recovered", described as "necrotic toes nearly healed then broke down again". the clinical course was reported as follows: tissue/skin necrosis of two toes on right foot soon after the 2nd astrazeneca (az) jab - took 6 months to nearly heal and when she had a 3rd booster jab with pfizer the toes broke down again within 2 weeks of administration. necrotic toes nearly healed then broke down again within 3weeks of having the 3rd booster jab. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
na
Liste des symptômes
interchange of vaccine products skin necrosis off label use disease recurrence extremity necrosis
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na